We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News Medica 2024 AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

AI-Powered Early Warning Solution Facilitates Timely Intervention

By HospiMedica International staff writers
Posted on 13 Mar 2018
PeriGen (Cary, NC, USA), a provider of perinatal early warning systems, delivered a sneak peek of PeriWatch Vigilance, its new fetal and maternal early warning platform, at the 2018 HIMSS Conference & Exhibition (HIMSS18).

PeriGen offers innovative perinatal software solutions, which incorporate artificial intelligence (AI) to enhance clinical efficiency and standardization of care during childbirth. The company’s new PeriWatch Vigilance early warning platform for obstetrics automatically identifies patients whose conditions are worsening, facilitating more timely interventions. The "always on" software uses proprietary intelligent algorithms to analyze maternal vital signs, fetal heart rate, contractions and labor progress in real time, alerting clinicians of emerging abnormalities. Specific thresholds and automated checklists can be configured according to the hospital’s preferences.

Image: The PeriWatch Vigilance is designed as a new fetal and maternal early warning platform (Photo courtesy of PeriGen).
Image: The PeriWatch Vigilance is designed as a new fetal and maternal early warning platform (Photo courtesy of PeriGen).

The enterprise-wide platform augments currently installed fetal surveillance systems, providing a critical layer of patient safety without requiring hospitals to "rip and replace" their current systems. Simple to implement, it allows clinicians to spend more time on direct patient care and less time on manual calculations and data manipulation.

"Delayed response to clinical warning signs is by far the leading human factor found in severe birth-related morbidity," said Matthew Sappern, CEO of PeriGen. "The tireless analyses performed by PeriWatch Vigilance help clinicians see worrisome trends at a glance, and intervene before it is too late. Use of early warning systems as well as the PeriWatch modules has been associated with a reduction in morbidity."

Related Links:
PeriGen

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
New
Blanket Warming Cabinet
EC250
New
Mattress Replacement System
Carilex DualPlus

Latest Business News

MEDICA 2024 to Highlight Hot Topics of MedTech Industry

Start-Ups To Once Again Play Starring Role at MEDICA 2024

Boston Scientific to Acquire AFib Ablation Company Cortex